FLT1 and head and neck carcinoma: Together with the study of Zhang et al. [36], which demonstrated that VEGFR1 expression is increased in tumour-associated ECs of head and neck carcinomas, these data emphasise the importance of evaluating VEGFR expression in human tissues to optimize targeted therapies.